Clinical Trial Update: Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial checking intraprostatic PRX302 injections for localized prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• PRX302

Snippet

Sponsor: Sophiris Bio Corp | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED